Shinhung

KO:004080 Korea Medical Devices
Market Cap
$88.17 Million
₩129.10 Billion KRW
Market Cap Rank
#28202 Global
#1877 in Korea
Share Price
₩13810.00
Change (1 day)
+0.07%
52-Week Range
₩13360.00 - ₩14750.00
All Time High
₩17558.58
Categories
Companies in Korea Medical Devices
About

Shinhung Co., Ltd. manufactures, imports, and sells dental products and supplies in South Korea. Its products include implant systems; dental units and chairs; dental alloys, such as composition tables, crowns, and porcelain under the Goldenian brand name; prefabricates SS crowns; taurus, insert, and mobile cabinets; compressors and mixers; dental needles; dental porcelain powder and laboratory p… Read more

Shinhung (004080) - Net Assets

Latest net assets as of September 2025: ₩116.48 Billion KRW

Based on the latest financial reports, Shinhung (004080) has net assets worth ₩116.48 Billion KRW as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩153.50 Billion) and total liabilities (₩37.02 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩116.48 Billion
% of Total Assets 75.88%
Annual Growth Rate 4.65%
5-Year Change 26.4%
10-Year Change 36.91%
Growth Volatility 4.52

Shinhung - Net Assets Trend (2000–2024)

This chart illustrates how Shinhung's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Shinhung (2000–2024)

The table below shows the annual net assets of Shinhung from 2000 to 2024.

Year Net Assets Change
2024-12-31 ₩116.16 Billion +1.99%
2023-12-31 ₩113.89 Billion +6.58%
2022-12-31 ₩106.86 Billion +5.37%
2021-12-31 ₩101.42 Billion +10.35%
2020-12-31 ₩91.90 Billion +4.49%
2019-12-31 ₩87.95 Billion +0.74%
2018-12-31 ₩87.31 Billion +1.09%
2017-12-31 ₩86.37 Billion +1.99%
2016-12-31 ₩84.68 Billion -0.19%
2015-12-31 ₩84.85 Billion +2.29%
2014-12-31 ₩82.95 Billion +6.49%
2013-12-31 ₩77.89 Billion +0.79%
2012-12-31 ₩77.28 Billion -0.69%
2011-12-31 ₩77.82 Billion +6.14%
2009-12-31 ₩73.32 Billion -0.25%
2008-12-31 ₩73.51 Billion +1.86%
2007-12-31 ₩72.16 Billion +3.04%
2006-12-31 ₩70.03 Billion +2.42%
2005-12-31 ₩68.38 Billion +11.37%
2004-12-31 ₩61.40 Billion +12.81%
2003-12-31 ₩54.43 Billion +13.96%
2002-12-31 ₩47.76 Billion +8.91%
2001-12-31 ₩43.85 Billion +12.35%
2000-12-31 ₩39.03 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Shinhung's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 10267740459000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ₩102.68 Billion 88.77%
Other Components ₩12.99 Billion 11.23%
Total Equity ₩115.67 Billion 100.00%

Shinhung Competitors by Market Cap

The table below lists competitors of Shinhung ranked by their market capitalization.

Company Market Cap
Quickfee Ltd
AU:QFE
 		$10.80 Million
Ridgetech, Inc.
NASDAQ:RDGT
 		$10.80 Million
Papercorea
KO:001020
 		$10.80 Million
Jeong Moon Information. Co. Ltd
KQ:033050
 		$10.80 Million
Chin Yang Chem
KO:051630
 		$10.80 Million
Alton Sports Co.Ltd
KQ:123750
 		$10.79 Million
Peace & Living PCL
BK:PEACE
 		$10.79 Million
Replenish Nutrients Holding Corp.
F:7KE
 		$10.79 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shinhung's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 113,890,708,950 to 115,668,884,700, a change of 1,778,175,750 (1.6%).
  • Net income of 5,228,581,700 contributed positively to equity growth.
  • Dividend payments of 2,497,964,210 reduced retained earnings.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩5.23 Billion +4.52%
Dividends Paid ₩2.50 Billion -2.16%
Other Changes ₩-952.44 Million -0.82%
Total Change ₩- 1.56%

Book Value vs Market Value Analysis

This analysis compares Shinhung's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.13x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 1.53x to 1.13x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 ₩9053.16 ₩13810.00 x
2018-12-31 ₩9149.55 ₩13810.00 x
2019-12-31 ₩9215.71 ₩13810.00 x
2020-12-31 ₩9622.90 ₩13810.00 x
2021-12-31 ₩10782.66 ₩13810.00 x
2022-12-31 ₩11398.27 ₩13810.00 x
2023-12-31 ₩12063.93 ₩13810.00 x
2024-12-31 ₩12242.03 ₩13810.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shinhung utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.52%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 5.14%
  • • Asset Turnover: 0.72x
  • • Equity Multiplier: 1.22x
  • Recent ROE (4.52%) is below the historical average (8.30%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2000 20.59% 9.85% 0.88x 2.39x ₩3.97 Billion
2001 17.92% 8.27% 1.03x 2.11x ₩3.34 Billion
2002 15.85% 7.18% 0.99x 2.23x ₩2.71 Billion
2003 16.95% 8.13% 0.99x 2.10x ₩3.67 Billion
2004 17.60% 9.05% 1.07x 1.82x ₩4.54 Billion
2005 13.05% 7.12% 1.03x 1.78x ₩2.03 Billion
2006 9.26% 4.45% 1.06x 1.97x ₩-507.58 Million
2007 6.26% 2.79% 1.17x 1.92x ₩-2.65 Billion
2008 2.69% 1.22% 1.10x 2.00x ₩-5.30 Billion
2009 2.22% 1.01% 1.14x 1.92x ₩-5.69 Billion
2011 3.81% 1.73% 1.19x 1.85x ₩-4.76 Billion
2012 1.31% 0.65% 1.09x 1.84x ₩-6.65 Billion
2013 1.80% 1.13% 0.96x 1.67x ₩-6.35 Billion
2014 8.15% 5.43% 1.01x 1.49x ₩-1.53 Billion
2015 3.49% 2.36% 0.92x 1.62x ₩-5.52 Billion
2016 1.36% 0.93% 0.95x 1.55x ₩-7.31 Billion
2017 3.67% 2.61% 0.92x 1.52x ₩-5.47 Billion
2018 3.50% 2.51% 0.92x 1.52x ₩-5.68 Billion
2019 2.32% 1.66% 0.84x 1.67x ₩-6.75 Billion
2020 13.53% 10.66% 0.80x 1.59x ₩3.24 Billion
2021 13.26% 10.60% 0.92x 1.37x ₩3.31 Billion
2022 7.92% 7.16% 0.84x 1.32x ₩-2.22 Billion
2023 8.10% 8.21% 0.80x 1.23x ₩-2.16 Billion
2024 4.52% 5.14% 0.72x 1.22x ₩-6.34 Billion

Industry Comparison

This section compares Shinhung's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $99,545,704,322
  • Average return on equity (ROE) among peers: 7.50%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Shinhung (004080) ₩116.48 Billion 20.59% 0.32x $10.80 Million
Osang Healthcare Co.,Ltd (036220) $199.86 Billion 20.34% 0.25x $37.44 Million
HansBiomed Corporation (042520) $43.16 Billion 11.38% 0.21x $246.58 Million
JVM Co. Ltd (054950) $98.83 Billion 10.23% 0.72x $117.37 Million
Huvitz Co. Ltd (065510) $51.68 Billion 16.97% 0.32x $43.64 Million
Vieworks Co. Ltd (100120) $188.04 Billion 17.80% 0.28x $101.54 Million
Corentec Co Ltd (104540) $48.30 Billion -3.04% 0.46x $40.80 Million
Hironic Co. Ltd (149980) $40.72 Billion 7.13% 0.15x $23.71 Million
Laseroptek Co., Ltd. (199550) $-3.94 Billion 0.00% 0.00x $21.68 Million
Humasis Co. Ltd (205470) $229.26 Billion -13.28% 0.45x $48.97 Million